Dyne Therapeutics (DYN) Preferred Shares (2019)

Dyne Therapeutics (DYN) recorded quarterly Preferred Shares of $27.4 million in Q4 2019.

Dyne Therapeutics (DYN) Preferred Shares (2019) Analysis & Trends

Dyne Therapeutics' Preferred Shares history runs 1 years deep, the most recent figure standing at $27.4 million for Q4 2019.

In Q4 2019, Preferred Shares changed N/A year-over-year to $27.4 million; the TTM figure through Dec 2019 stood at $27.4 million (changed N/A YoY), while the FY2019 annual figure was $27.4 million, changed N/A from the prior year.
Preferred Shares was $27.4 million for Q4 2019 at Dyne Therapeutics.
In the past five years, Preferred Shares ranged from a high of $27.4 million in Q4 2019 to a low of $27.4 million in Q4 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	-
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Dyne Therapeutics	3.00 Bn	3.00 Bn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2019	27.43 Mn